| Authors: |
Lunenberg RA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Franken IA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van der Baan FH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Sijtsma FPC; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., Vink GR; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., Braat MNGJA; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands., Moons LMG; Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, The Netherlands., Lacle MM; Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands., Elferink MAG; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., Boklage S; Global Real World Evidence and Health Outcomes, GSK, Collegeville, Pennsylvania, USA., Intven MPW; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Garside J; Global Real World Evidence and Health Outcomes, GSK, London, UK., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Wuijtswinkel R; Medical Affairs Oncology, GSK, Amersfoort, The Netherlands., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. |
